ask="41.00"
ask_size="100"
average_daily_volume="1265050"
bid="39.43"
bid_size="1000"
book_value="11.83"
change="-2.55"
change_from_200_day_moving_average="-12.35"
change_from_50_day_moving_average="0.22"
change_from_52_week_high="-39.65"
change_From_52_week_low="9.08"
change_in_percent="-5.93%"
close="40.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.79"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-4.94"
ex_dividend_date="N/A"
float_shares="70877000"
high="43.33"
high_52_weeks="80.11"
last_trade_date="2/7/2017"
last_trade_price="40.46"
last_trade_size="65465"
last_trade_time="4:00pm"
low="40.12"
low_52_weeks="31.38"
market_capitalization="3.47B"
moving_average_200_day="52.81"
moving_average_50_day="40.24"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="64.33"
open="43.19"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="-23.39%"
percent_change_from_50_day_moving_average="+0.55%"
percent_change_from_52_week_high="-49.49%"
percent_change_from_52_week_low="+28.94%"
previous_close="43.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.63"
price_per_sales="99.07"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="976106"
weeks_range_52="31.38 - 80.11"
